E2F7 Antikörper (Middle Region)
Kurzübersicht für E2F7 Antikörper (Middle Region) (ABIN952014)
Target
Alle E2F7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 590-619, Middle Region
-
Spezifität
- This antibody recognizes Human E2F7 (Center).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 590-619 amino acids from the Central region of Human E2F7
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- E2F7 (E2F Transcription Factor 7 (E2F7))
-
Andere Bezeichnung
- E2F7
-
Hintergrund
- Along with E2F8, inhibitor of E2F-dependent transcription that is important for the control of the E2F1-TP53 apoptotic pathway. Directly represses E2F1 transcription (By similarity). Binds DNA independently of DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3'. Appears to regulate a subset of E2F-dependent genes whose products are required for normal cell cycle progession.Synonyms: E2F transcription factor 7, E2F-7, FLJ12981, Transcription factor E2F7
-
Molekulargewicht
- 99888 Da
-
Gen-ID
- 144455
-
NCBI Accession
- NP_976328
Target
-